GSE,Sample_title,Sample_geo_accession,Sample_status,Sample_submission_date,Sample_last_update_date,Sample_type,Sample_channel_count,Sample_source_name_ch1,Sample_organism_ch1,Sample_taxid_ch1,Sample_treatment_protocol_ch1,Sample_growth_protocol_ch1,Sample_molecule_ch1,Sample_extract_protocol_ch1,Sample_data_processing,Sample_platform_id,Sample_contact_name,Sample_contact_institute,Sample_contact_address,Sample_contact_city,Sample_contact_zip/postal_code,Sample_contact_country,Sample_instrument_model,Sample_library_selection,Sample_library_source,Sample_library_strategy,Sample_series_id,Sample_data_row_count,file,file_url,sample_name,file_size,type,BioSample,SRA,subtype,tissue,passages,genotype,description,Genome_build,Supplementary_files_format_and_content
GSE141351,ATAC-seq from Basal1,GSM4201661,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201661_Basal1_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201661/suppl/GSM4201661_Basal1_ATAC.norm.bw,ATAC-seq from Basal1,412392878,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471369,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal1,GSM4201661,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201661_Basal1_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201661/suppl/GSM4201661_Basal1_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal1,1887714,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471369,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2,GSM4201662,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201662_Basal2_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201662/suppl/GSM4201662_Basal2_ATAC.norm.bw,ATAC-seq from Basal2,350640828,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471368,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2,GSM4201662,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201662_Basal2_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201662/suppl/GSM4201662_Basal2_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal2,2368497,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471368,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal1/FOXA1 o.e tumor,GSM4201663,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201663_Basal1_FOXA1_o.e_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201663/suppl/GSM4201663_Basal1_FOXA1_o.e_tumor_ATAC.norm.bw,ATAC-seq from Basal1/FOXA1 o.e tumor,340677922,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471367,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,FOXA1 was overexpressed in basal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal1/FOXA1 o.e tumor,GSM4201663,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201663_Basal1_FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201663/suppl/GSM4201663_Basal1_FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal1/FOXA1 o.e tumor,1692155,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471367,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,FOXA1 was overexpressed in basal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2/FOXA1 o.e tumor,GSM4201664,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201664_Basal2_FOXA1_o.e_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201664/suppl/GSM4201664_Basal2_FOXA1_o.e_tumor_ATAC.norm.bw,ATAC-seq from Basal2/FOXA1 o.e tumor,332387419,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471366,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,FOXA1 was overexpressed in basal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2/FOXA1 o.e tumor,GSM4201664,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201664_Basal2_FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201664/suppl/GSM4201664_Basal2_FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal2/FOXA1 o.e tumor,2011964,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471366,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,FOXA1 was overexpressed in basal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal1/BMP o.e CAF,GSM4201665,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201665_Basal1_BMP_o.e_CAF_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201665/suppl/GSM4201665_Basal1_BMP_o.e_CAF_ATAC.norm.bw,ATAC-seq from Basal1/BMP o.e CAF,301086136,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471365,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal1/BMP o.e CAF,GSM4201665,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201665_Basal1_BMP_o.e_CAF_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201665/suppl/GSM4201665_Basal1_BMP_o.e_CAF_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal1/BMP o.e CAF,2106857,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471365,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2/BMP o.e CAF,GSM4201666,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201666_Basal2_BMP_o.e_CAF_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201666/suppl/GSM4201666_Basal2_BMP_o.e_CAF_ATAC.norm.bw,ATAC-seq from Basal2/BMP o.e CAF,371923969,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471364,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2/BMP o.e CAF,GSM4201666,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201666_Basal2_BMP_o.e_CAF_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201666/suppl/GSM4201666_Basal2_BMP_o.e_CAF_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal2/BMP o.e CAF,2382959,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471364,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,wild type,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal1/BMP o.e CAF-FOXA1 k.o tumor,GSM4201667,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201667_Basal1_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201667/suppl/GSM4201667_Basal1_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC.norm.bw,ATAC-seq from Basal1/BMP o.e CAF-FOXA1 k.o tumor,269331529,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471363,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,FOXA1-/-,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal1/BMP o.e CAF-FOXA1 k.o tumor,GSM4201667,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201667_Basal1_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201667/suppl/GSM4201667_Basal1_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal1/BMP o.e CAF-FOXA1 k.o tumor,1995473,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471363,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,FOXA1-/-,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2/BMP o.e CAF-FOXA1 k.o tumor,GSM4201668,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201668_Basal2_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201668/suppl/GSM4201668_Basal2_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC.norm.bw,ATAC-seq from Basal2/BMP o.e CAF-FOXA1 k.o tumor,376507695,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471362,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,FOXA1-/-,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Basal2/BMP o.e CAF-FOXA1 k.o tumor,GSM4201668,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201668_Basal2_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201668/suppl/GSM4201668_Basal2_BMP_o.e_CAF-FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Basal2/BMP o.e CAF-FOXA1 k.o tumor,1966847,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471362,https://www.ncbi.nlm.nih.gov/sra?term,basal,Bladder tumor,7-10,FOXA1-/-,"BMP4, 5 were overexpressed in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1,GSM4201669,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201669_Luminal1_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201669/suppl/GSM4201669_Luminal1_ATAC.norm.bw,ATAC-seq from Luminal1,461878370,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471397,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1,GSM4201669,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201669_Luminal1_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201669/suppl/GSM4201669_Luminal1_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal1,2721002,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471397,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2,GSM4201670,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201670_Luminal2_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201670/suppl/GSM4201670_Luminal2_ATAC.norm.bw,ATAC-seq from Luminal2,329176654,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471396,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2,GSM4201670,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201670_Luminal2_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201670/suppl/GSM4201670_Luminal2_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal2,1838460,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471396,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,control,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1/FOXA1 k.o tumor,GSM4201671,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201671_Luminal1_FOXA1_k.o_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201671/suppl/GSM4201671_Luminal1_FOXA1_k.o_tumor_ATAC.norm.bw,ATAC-seq from Luminal1/FOXA1 k.o tumor,286104782,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471395,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,FOXA1-/-,FOXA1 was knocked out in luminal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1/FOXA1 k.o tumor,GSM4201671,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201671_Luminal1_FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201671/suppl/GSM4201671_Luminal1_FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal1/FOXA1 k.o tumor,2131815,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471395,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,FOXA1-/-,FOXA1 was knocked out in luminal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2/FOXA1 k.o tumor,GSM4201672,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201672_Luminal2_FOXA1_k.o_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201672/suppl/GSM4201672_Luminal2_FOXA1_k.o_tumor_ATAC.norm.bw,ATAC-seq from Luminal2/FOXA1 k.o tumor,406585221,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471394,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,FOXA1-/-,FOXA1 was knocked out in luminal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2/FOXA1 k.o tumor,GSM4201672,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201672_Luminal2_FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201672/suppl/GSM4201672_Luminal2_FOXA1_k.o_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal2/FOXA1 k.o tumor,3128958,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471394,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,FOXA1-/-,FOXA1 was knocked out in luminal tumor organoid,hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1/BMP k.o CAF,GSM4201673,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201673_Luminal1_BMP_k.o_CAF_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201673/suppl/GSM4201673_Luminal1_BMP_k.o_CAF_ATAC.norm.bw,ATAC-seq from Luminal1/BMP k.o CAF,326860318,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471393,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1/BMP k.o CAF,GSM4201673,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201673_Luminal1_BMP_k.o_CAF_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201673/suppl/GSM4201673_Luminal1_BMP_k.o_CAF_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal1/BMP k.o CAF,1819389,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471393,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2/BMP k.o CAF,GSM4201674,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201674_Luminal2_BMP_k.o_CAF_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201674/suppl/GSM4201674_Luminal2_BMP_k.o_CAF_ATAC.norm.bw,ATAC-seq from Luminal2/BMP k.o CAF,365746517,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471392,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2/BMP k.o CAF,GSM4201674,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201674_Luminal2_BMP_k.o_CAF_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201674/suppl/GSM4201674_Luminal2_BMP_k.o_CAF_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal2/BMP k.o CAF,2828606,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471392,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1/BMP k.o CAF-FOXA1 o.e tumor,GSM4201675,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201675_Luminal1_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201675/suppl/GSM4201675_Luminal1_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC.norm.bw,ATAC-seq from Luminal1/BMP k.o CAF-FOXA1 o.e tumor,332429163,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471427,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal1/BMP k.o CAF-FOXA1 o.e tumor,GSM4201675,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201675_Luminal1_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201675/suppl/GSM4201675_Luminal1_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal1/BMP k.o CAF-FOXA1 o.e tumor,2020492,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471427,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2/BMP k.o CAF-FOXA1 o.e tumor,GSM4201676,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201676_Luminal2_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC.norm.bw,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201676/suppl/GSM4201676_Luminal2_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC.norm.bw,ATAC-seq from Luminal2/BMP k.o CAF-FOXA1 o.e tumor,346865927,BW,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471426,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
GSE141351,ATAC-seq from Luminal2/BMP k.o CAF-FOXA1 o.e tumor,GSM4201676,Public on Sep 27 2020,Dec 03 2019,Sep 28 2020,SRA,1,Human bladder tumor organoid,Homo sapiens,9606,Human bladder tumor assembloids samples were harvested after 7 days of cultures with shaking incubation.,"Maintenance of human bladder tumor assembloids were conducted in organoid media.  Organoid media: Advanced DMEM/F-12 (Gibco) supplemented with 10 mM HEPES (pH 7.4, Sigma), 10 mM Nicotinamide (Sigma), 1 mM N-acetyl-L-cysteine (Sigma), 1X Glutamax (Gibco), 1% penicillin/streptomycin (Gibco), 50 ng/ml human EGF (Peprotech), 0.5X B-27 (Gibco), 1 μM A83-01 (Tocris), and 10 μM Y-27632 (Abmole)",genomic DNA,"We lysed 50,000 cells with 50 μl of Lysis buffer (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40, 0.1% Tween-20, and 0.01% Triton X-100) and incubated them for 5 min on ice . Following centrifuging at 1,000 g for 10 min at 4 °C, we resuspended the nuclei pellets with 50 μl of transposition mix (25 μl 2X TD buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, and 20% Dimethyl Formamide in sterile water) and 2.5 μl transposase (100 nM final), 16.5 μl PBS, 0.01% Triton X-100, 0.1% Tween-20, and 5 μl H2O) and incubated the mixture with shaking for 1 h at 55 °C in a thermomixer. We purified transposed DNA using DNA Clean and the Concentrator-5 Kit (Zymo Research)., We amplified the transposed DNA using the NEBNext® High-Fidelity 2X PCR Master Mix for 10 cycles. We then performed ATAC-Seq using the Illumina HiSeq 2500 platform.","FastQC-0.11.5 checked the quality of raw sequences. cutadapt-1.18 was used to detect and remove Illumina adapter sequence., Bowtie2-2.3.4.1 aligned sequences to the Homo sapiens genome (Ensembl GRCh38 release97). QualiMap-2.2.1 checked the quality of the alignment., Picard tools removed duplicates with parameters ""VALIDATION_STRINGENCY, The reads were offset by +4 bases for the + strand and -5 bases for the - strand., MACS2-v2.1.2 was used for peak calling with parameters ""--nomodel --shift -100 --extsize 200"" and q-value < 0.01.",GPL16791,"Tae-Young,,Roh",POSTECH,77 Cheongam-Ro,Pohang,37673,South Korea,Illumina HiSeq 2500,other,genomic,ATAC-seq,"GSE141351, GSE141356",0,GSM4201676_Luminal2_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4201nnn/GSM4201676/suppl/GSM4201676_Luminal2_BMP_k.o_CAF-FOXA1_o.e_tumor_ATAC_peaks.narrowPeak.gz,ATAC-seq from Luminal2/BMP k.o CAF-FOXA1 o.e tumor,2180169,NARROWPEAK,https://www.ncbi.nlm.nih.gov/biosample/SAMN13471426,https://www.ncbi.nlm.nih.gov/sra?term,luminal,Bladder tumor,7-10,wild type,"BMP4, 5 were knocked out in surrounding reconstituted CAF",hg38,narrowPeak files were generated using MACS2; bigWig files were generated using genomeCoverageBed and bedGraphToBigWig.
